Open AccessChanges in US Clinician Waivers to Prescribe Buprenorphine Management for Opioid Use Disorder During the COVID-19 Pandemic and After Relaxation of Training Requirements
Author(s) -
Joanne Spetz,
Laurie Hailer,
Caryl Gay,
Matthew Tierney,
Laura A. Schmidt,
Bethany J. Phoenix,
Susan Chapman
Publication year - 2022
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2022.5996
Subject(s) - buprenorphine , covid-19 , opioid use disorder , pandemic , medicine , opioid , drug , psychiatry , virology , receptor , disease , outbreak , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom